Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to $11.3 million.

  • Nurix Therapeutics' Amortizatization of Intangibles fell 40.72% to $2.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $11.9 million, marking a year-over-year increase of 24.23%. This contributed to the annual value of $11.3 million for FY2024, which is 84.41% up from last year.
  • As of FY2024, Nurix Therapeutics' Amortizatization of Intangibles stood at $11.3 million, which was up 84.41% from $6.1 million recorded in FY2023.
  • Nurix Therapeutics' 5-year Amortizatization of Intangibles high stood at $11.3 million for FY2024, and its period low was -$273,000 during FY2020.
  • In the last 3 years, Nurix Therapeutics' Amortizatization of Intangibles had a median value of $6.1 million in 2023 and averaged $7.6 million.
  • Per our database at Business Quant, Nurix Therapeutics' Amortizatization of Intangibles tumbled by 350.46% in 2020 and then soared by 1,305.86% in 2021.
  • Nurix Therapeutics' Amortizatization of Intangibles (Yearly) stood at -$273,000 in 2020, then spiked by 1,305.86% to $3.3 million in 2021, then surged by 65.83% to $5.5 million in 2022, then climbed by 12.13% to $6.1 million in 2023, then skyrocketed by 84.41% to $11.3 million in 2024.